Mycosyst-Gyno (Fluconazole)

Fluconazole inhibits the fungal enzyme lanosterol 14α‑demethylase, which is essential for producing ergosterol, a key component of fungal cell membranes. By blocking ergosterol synthesis, the drug compromises membrane integrity, leading to inhibited growth and eventual death of the fungus.

The specific dose of Mycosyst-Gyno is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and other individual factors. Healthcare professionals should follow current clinical guidelines and adjust the regimen as needed.

Safety of fluconazole during pregnancy or lactation depends on the dose and duration of therapy. Single low‑dose treatments are sometimes considered acceptable, but higher or prolonged courses may pose risks. Physicians should evaluate the benefit‑risk ratio and discuss alternatives when appropriate.

To order Mycosyst-Gyno, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Fluconazole, the active ingredient in Mycosyst-Gyno, offers oral convenience and a broad spectrum against Candida species, often preferred over older azoles like ketoconazole due to better tolerability and fewer drug‑interaction concerns. Compared with newer agents such as itraconazole, fluconazole has a simpler dosing schedule but may be less effective against resistant strains.

Mycosyst-Gyno should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency throughout its shelf life.

Mycosyst-Gyno is taken orally, usually as a single dose or a short course as directed by a healthcare professional. The tablet should be swallowed whole with water and can be taken with or without food, unless otherwise advised by the prescriber.

Serious risks include hepatotoxicity, severe allergic reactions such as anaphylaxis, and rare skin disorders like Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience signs of liver injury (e.g., jaundice), rash, or difficulty breathing.

Mycosyst-Gyno is contraindicated in individuals with a known hypersensitivity to fluconazole or any other azole antifungal. Caution is also advised for patients with severe liver disease, and it should be avoided in those taking medications that have a high risk of dangerous interactions unless closely monitored.